Acquiring Company
Curaleaf
Acquired Company
Four 20 Pharma GmbH
Stamford
GermanyManufacturingAgriculture and FarmingMedia And EntertainmentCommunity And LifestyleHealth CareCannabisDescription
Curaleaf Holdings, Inc. (CSE: CURA) ( OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced the completion of its agreement to acquire a 55% stake in Four 20 Pharma GmbH, a fully EU-GMP & GDP licensed German producer and distributor of medical cannabis.
Quick answer
Curaleaf is acquiring Four 20 Pharma GmbH, announced September 19, 2022. Curaleaf is based in Stamford, Connecticut, United States.
- How much did Curaleaf pay for Four 20 Pharma GmbH?
- The deal value was not disclosed.
- What does Curaleaf do?
- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of..
- Where are Curaleaf and Four 20 Pharma GmbH based?
- Curaleaf is based in Stamford, Connecticut, United States. Four 20 Pharma GmbH is based in Germany.
- Who are the decision-makers at Curaleaf?
- Fundz holds 3 contacts at Curaleaf. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Agriculture and Farming and Media And Entertainment
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Curaleaf Completes Acquisition Of Tryke Companies (October 5, 2022)
- Geistlich Pharma North America, Inc. Acquires Lynch Biologics, Llc, A Biologics And Tissue Engineering Company (October 27, 2022)
- Collagen Matrix Acquires Polyganics (October 5, 2022)
- Icanic Brands Announces Non-Binding Loi To Acquire The Leaf At 73740 Llc (September 19, 2022)
- Bristol Myers Squibb And Turning Point Therapeutics Announce Expiration Of Hsr Act Waiting Period And Clearance From Federal Cartel Office Of Germany Related To Pending Acquisition Of Turning Point Therapeutics (August 16, 2022)
- Foam Holdings Acquires Amvic And Concrete Block Insulating Systems (November 3, 2022)
Who to call at Curaleaf, and when
When Curaleaf changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Curaleaf raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Curaleaf, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Curaleaf. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Curaleaf makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Four 20 Pharma GmbH?
Four 20 Pharma GmbH was acquired by Curaleaf, based in Stamford. The deal was reported on September 19, 2022. Curaleaf Holdings, Inc. Curaleaf is publicly traded (CURLF) and operates in Manufacturing.
When did Curaleaf acquire Four 20 Pharma GmbH?
Curaleaf's acquisition of Four 20 Pharma GmbH was reported on September 19, 2022. Curaleaf Holdings, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Four 20 Pharma GmbH do?
Four 20 Pharma GmbH is a fully EU-GMP and GDP licensed producer and distributor of medical cannabis in Germany. The company is recognized for its high-quality cultivation and pharmaceutical-grade processing. It is privately held, and is based in Germany.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.